Ckrogers
Contributor
Hello,
This has been an ongoing discussion in my office and we cannot settle on an answer, I would like your opinions. In this case the patient has had a prostate biopsy performed by our providers. When the biopsy results confirm cancer, a patient is brought in to discuss the results. The cancer would fall into high complexity, no new data is reviewed except our biopsy results so that is straightforward. Our issue then is the risk management and we have been unsure of Moderate vs. High. The doctor gives many options for medication, and surgery with risk at a moderate level. The main problem is a referral for radiation oncology. Does this referral qualify as drug therapy requiring intensive monitoring of toxicity, making it High level patient management? Please help us settle this debate.
Thanks
This has been an ongoing discussion in my office and we cannot settle on an answer, I would like your opinions. In this case the patient has had a prostate biopsy performed by our providers. When the biopsy results confirm cancer, a patient is brought in to discuss the results. The cancer would fall into high complexity, no new data is reviewed except our biopsy results so that is straightforward. Our issue then is the risk management and we have been unsure of Moderate vs. High. The doctor gives many options for medication, and surgery with risk at a moderate level. The main problem is a referral for radiation oncology. Does this referral qualify as drug therapy requiring intensive monitoring of toxicity, making it High level patient management? Please help us settle this debate.
Thanks